发明名称 |
NEW PHYSIOLOGICALLY ACTIVE PEPTIDE AND ITS USE |
摘要 |
<p>PROBLEM TO BE SOLVED: To provide a new physiologically active peptide having smooth muscle relaxation action and sodium diuretic action of known sodium diuretic peptide and useful as an agent for the treatment of circulatory diseases. SOLUTION: The objective compound is expressed by the formula (X is H or the like; Asp is L-aspartic acid; Ser is L-serine; Gly is glycine; Cys is L-cysteine; Phe is L-phenylalanine; Arg is L-arginine; Leu is L-leucine; Ile is L-isoleucine; Asn is L-asparagine; Val is L-valine; Tyr is L=tyrosine; Lys is lysine; Met is methionine; His is histidine), e.g. human cerebral sodium diuretic peptide 26. The compound can be produced e.g. by introducing a protected His derivative into a p-alkoxybenzyl alcohol resin, successively bonding corresponding protecting amino acids to the product to synthesize a protected peptide resin, subjecting the resin to the cutting of peptide and the removal of the protecting groups from the resin and finally purifying the product.</p> |
申请公布号 |
JPH11343299(A) |
申请公布日期 |
1999.12.14 |
申请号 |
JP19990121666 |
申请日期 |
1999.04.28 |
申请人 |
SHIONOGI & CO LTD;MATSUO TOSHIYUKI |
发明人 |
SUDO TETSUJI;IZUMI ATSUSHI;TAKASHIMA MIKA;MATSUO TOSHIYUKI |
分类号 |
A61K38/00;A61K31/00;A61P9/00;A61P9/04;A61P9/12;A61P13/00;A61P13/02;A61P13/12;C07K14/575;(IPC1-7):C07K14/575 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|